← Back to search

CURIA GLOBAL INC

ALBANY, NY, 12203

Prime contracting experience

49 records from government sources. Past participation is not evidence of current teaming interest.

RoleAgencyDescriptionVehicleObligatedAction datePeriod
Prime
Department of Health and Human Services
National Institutes of Health
CMC DEVELOPMENT OF (R)-VK4-116 DIHYDROCHLORIDE SALTHHSN271201700005IUSAspending$1,795,195Sep 24, 2026Sep 21, 2020 – Mar 31, 2026
Prime
Department of Health and Human Services
National Institutes of Health
MCSP TORFP NO. NIH-NINDS-20-03: KATRITCH (USC) - BASE EC (PAIN)HHSN271201800001IUSAspending$3,167,871Sep 18, 2026Jun 1, 2020 – Jul 1, 2024
Prime
Department of Health and Human Services
National Institutes of Health
EXPLORATORY CHEMISTRY. MEDICINAL CHEMISTRY SUPPORT PROGRAM FOR THERAPEUTIC DEVELOPMENT (MCSP). POP: SEPTEMBER 21, 2026 TO MARCH 20, 2028. DAP-NCAP-00000137.HHSN271201800001IUSAspending$692,173Sep 18, 2026Sep 21, 2026 – Mar 20, 2028
Prime
Department of Health and Human Services
National Institutes of Health
EXPLORATORY CHEMISTRY. MEDICINAL CHEMISTRY SUPPORT PROGRAM FOR THERAPEUTIC DEVELOPMENT (MCSP). POP: SEPTEMBER 21, 2026 TO MARCH 20, 2028. DAP-NCAP-00000137.HHSN271201800001IUSAspending$669,175Sep 18, 2026Sep 21, 2026 – Mar 20, 2028
Prime
Department of Health and Human Services
National Institutes of Health
EXPLORATORY CHEMISTRY AND HIT-TO-LEAD CHEMISTRY OPTION. MEDICINAL CHEMISTRY SUPPORT PROGRAM FOR THERAPEUTIC DEVELOPMENT (MCSP). POP: SEPTEMBER 21, 2026 TO MARCH 20, 2029. DAP-NCAP-00000137HHSN271201800001IUSAspending$2,138,209Sep 18, 2026Sep 21, 2026 – Mar 20, 2029
Prime
Department of Health and Human Services
National Institutes of Health
ALBANY MOLECULAR RESEARCH INC - BOZIK BPN 25203HHSN271201500005IUSAspending$1,771,111Sep 14, 2026Sep 10, 2019 – Sep 12, 2024
Prime
Department of Health and Human Services
National Institutes of Health
IGF::OT::IGF DRUG MANUFACTURING AND FORMULATION PROGRAM (DMFP) TASK ORDER #01: PERFORMANCE ACTIVITY 1 TECHNICAL SUPPORT (1/15/15 / 1/14/16)HHSN271201500005IUSAspending$273,065Sep 11, 2026Jan 15, 2015 – Jan 14, 2025
Prime
Department of Health and Human Services
National Institutes of Health
KATRITCH- UNIVERSITY OF SOUTHERN CALIFORNIA DMFP FOR BPN-35269 - CURIA GLOBAL, INC.HHSN271201500005IUSAspending$2,451,019Aug 5, 2026Sep 13, 2023 – Sep 12, 2029
Prime
Department of Health and Human Services
National Institutes of Health
NONCLINICAL SERVICES - SCALE-UP SYNTHESIS OF APX2039, A NOVEL GWT1 ENZYME INHIBITOR IN FUNGI75N93018D00008USAspending$620,125Jul 16, 2026Aug 27, 2020 – Sep 30, 2021
Prime
Department of Health and Human Services
National Institutes of Health
NON-GMP SYNTHESIS OF COMPOUNDS. POP: 9/19/24-9/18/25.—$884,003Jun 26, 2026Sep 19, 2024 – Sep 18, 2027
Prime
Department of Health and Human Services
National Institutes of Health
IGF::OT::IGF DMFP TASK ORDER NO. 5 BUCKPITT BPN 19186HHSN271201500005IUSAspending$1,191,883Sep 15, 2025Feb 5, 2016 – Jun 29, 2022
Prime
Department of Health and Human Services
National Institutes of Health
NIH BLUEPRINT NEUROTHERAPEUTICS NETWORK (BPN) MEDICINAL CHEMISTRY SUPPORT PROGRAM (MCSP)HHSN271201800001IUSAspending$251,981Sep 15, 2025Feb 24, 2020 – Sep 1, 2021
Prime
Department of Health and Human Services
National Institutes of Health
MCSP TORFP NO. NIH-NINDS-20-04: CHILDERS - BASE EC [SUBSTANCE USE DISORDER (COCAINE)]HHSN271201800001IUSAspending$631,254Aug 29, 2025Jun 1, 2020 – Sep 30, 2021
Prime
Department of Health and Human Services
National Institutes of Health
FLORIO BPN PROJECT BPN-36938HHSN271201500005IUSAspending$2,502,592Aug 18, 2025Sep 17, 2024 – Sep 16, 2030
Prime
Department of Health and Human Services
National Institutes of Health
CHEMISTRY AND MANUFACTURING SERVICES - TASK C10 CHEMICAL SYNTHESIS AND PROCESS OPTIMIZATION OF STF-175975N93018D00008USAspending$411,405Jul 10, 2025Jul 31, 2020 – Sep 30, 2021
Prime
Department of Health and Human Services
National Institutes of Health
FEASIBILITY STUDIES, CLINICAL TRIAL READINESS, GMP/CLINICAL TRIAL MATERIALSHHSN271201500005IUSAspending$1,135,800Jun 2, 2025Jul 6, 2022 – Jun 2, 2025
Prime
Department of Health and Human Services
National Institutes of Health
MCSP TORFP NO. NIH-NINDS-21-02: TRUSHINA (MEDCHEM) - BASE EXPLORATORY CHEMISTRY (ALZHEIMER'S DISEASE)HHSN271201800001IUSAspending$607,397Jun 2, 2025Feb 4, 2021 – Jun 2, 2025
Prime
Department of Health and Human Services
National Institutes of Health
ALBANY MOLECULAR RESEARCH, INC(AMRI)[19-002417]MCSP TASK ORDER XU PROJECT - EXPLORATORY CHEMISTRY POP: TBDHHSN271201800001IUSAspending$555,782Apr 28, 2025Nov 30, 2018 – Apr 28, 2025
Prime
Department of Health and Human Services
National Institutes of Health
MCNAMARA EXPLORATORY CHEMISTRYHHSN271201800001IUSAspending$2,869,424Apr 3, 2025May 1, 2019 – Nov 30, 2022
Prime
Department of Health and Human Services
National Institutes of Health
MULCAHY EXPLORATORY CHEMISTRYHHSN271201800001IUSAspending$1,804,475Apr 2, 2025May 2, 2019 – Nov 30, 2022
Prime
Department of Health and Human Services
National Institutes of Health
IGF::OT::IGF TASK ORDER NO. 2 - "VAN LEYEN MCSP-EC"HHSN271201800001IUSAspending$3,403,139Feb 26, 2025May 4, 2018 – Oct 31, 2021
Prime
Department of Health and Human Services
National Institutes of Health
CHEMISTRY, MANUFACTURING, AND CONTROLS (CMC) DEVELOPMENT OF NCGC00413972 FOR PRECLINICAL SAFETY EVALUATION AND CLINICAL TRIALHHSN271201700005IUSAspending$907,792Dec 20, 2024Sep 30, 2023 – Apr 30, 2028
Prime
Department of Health and Human Services
National Institutes of Health
BPN-MCSP-HIT TO LEAD CHEMISTRY- MARTIN (NUVONURO)HHSN271201800001IUSAspending$922,304Dec 12, 2024Dec 9, 2024 – Jun 8, 2026
Prime
Department of Health and Human Services
National Institutes of Health
PRODUCTION OF NON-GMP BATCHES OF PAYNANTHEINE, SPECIOGYNINE, AND SPECIOCILIATINE SALTSHHSN271201700005IUSAspending$1,174,494Nov 26, 2024Sep 16, 2020 – Apr 30, 2025
Prime
Department of Health and Human Services
National Institutes of Health
NONCLINICAL SERVICES FOR THE DEVELOPMENT OF INTERVENTIONAL AGENTS FOR INFECTIOUS DISEASES.75N93018D00008USAspending$1,905,868Nov 13, 2024Jul 19, 2024 – Jan 18, 2026
Prime
Department of Health and Human Services
National Institutes of Health
HIT TO LEAD CHEMISTRY UNDER PERFORMANCE AREA 2 OF ID/IQ CONTRACT NO. HHSN271201800001IHHSN271201800001IUSAspending$1,796,372Oct 10, 2024Sep 27, 2022 – Apr 14, 2026
Prime
Department of Health and Human Services
National Institutes of Health
ALBANY MOLECULAR RESEARCH INC - ROSENZWEIGHHSN271201500005IUSAspending$1,022,104Sep 27, 2024Sep 16, 2019 – Sep 29, 2024
Prime
Department of Health and Human Services
National Institutes of Health
TAS::75 0886::TAS MEDICINAL CHEMISTRY FOR NEUROTHERAPEUTICS PROGRAM (MCNP)—$27,277,165Sep 27, 2024Aug 17, 2011 – Apr 15, 2019
Prime
Department of Health and Human Services
National Institutes of Health
SPIGELMAN (UCLA) - MCSP- EXPLORATORY CHEMISTRY (EC)HHSN271201800001IUSAspending$1,981,927Sep 6, 2024Aug 18, 2023 – Mar 4, 2026
Prime
Department of Health and Human Services
National Institutes of Health
MANUFACTURE OF 5.5-KG CGMP MITRAGYNINEHHSN271201700005IUSAspending$2,791,010Aug 2, 2024Aug 22, 2019 – May 31, 2024
Prime
Department of Health and Human Services
National Institutes of Health
MEDICINAL CHEMISTRY SERVICES TO SUPPORT PROJECT "ALDRICH (UNIV. OF FLORIDA) - EXPLORATORY CHEMISTRY-ADMET ONLY - MCSP"HHSN271201800001IUSAspending$404,158Jun 24, 2024May 12, 2023 – Dec 14, 2025
Prime
Department of Health and Human Services
National Institutes of Health
TO AWARD TASK C0275N93018D00008USAspending$542,766Jun 6, 2024Mar 22, 2019 – Mar 21, 2020
Prime
Department of Health and Human Services
National Institutes of Health
TO AWARD TASK C0375N93018D00008USAspending$860,163Jun 6, 2024Apr 12, 2019 – Apr 11, 2020
Prime
Department of Health and Human Services
National Institutes of Health
TO C-06: PREPARATION OF 400 GRAMS OF NON-GMP ANTIBIOTIC CANDIDATE FG-960-275N93018D00008USAspending$610,341Jun 6, 2024Aug 20, 2019 – May 19, 2020
Prime
Department of Health and Human Services
National Institutes of Health
MARTIN (NUVONURO)-HIT TO LEAD CHEMISTRY-ADMET ONLY- MCSP-HEALHHSN271201800001IUSAspending$256,491May 29, 2024Aug 1, 2023 – Feb 1, 2025
Prime
Department of Health and Human Services
National Institutes of Health
SHAMLOO (STANDFORD UNIVERSITY) - MCSP-EXPLORATORY CHEMISTRY (EC)HHSN271201800001IUSAspending$3,360,769May 29, 2024May 6, 2022 – Nov 13, 2025
Prime
Department of Health and Human Services
National Institutes of Health
SCALE UP FERMENTATION AND ISOLATION OF MEDINAMYCIN75N93018D00008USAspending$554,127May 14, 2024Jan 3, 2022 – Sep 30, 2024
Prime
Department of Health and Human Services
National Institutes of Health
AL-ALI (UNIVERSITY OF MIAMI, SCHOOL OF MEDICINE) - MCSP - EXPLORATORY CHEMISTRY (EC)HHSN271201800001IUSAspending$3,173,499Mar 26, 2024Feb 1, 2022 – Feb 1, 2026
Prime
Department of Health and Human Services
National Institutes of Health
HIT TO LEAD CHEMISTRY UNDER PERFORMANCE AREA 2 OF ID/IQ CONTRACT NO. HHSN271201800001IHHSN271201800001IUSAspending$1,471,823Dec 28, 2023Jul 27, 2022 – Sep 1, 2024
Prime
Department of Health and Human Services
National Institutes of Health
MANUFACTURE OF MBX-40075N93018D00008USAspending$1,056,500Sep 27, 2023Sep 1, 2022 – Oct 31, 2023
Prime
Department of Health and Human Services
National Institutes of Health
TSUKAMOTO (JOHNS HOPKINS UNIVERSITY) MCSP - LEAD OPTIMIZATION CHEMISTRYHHSN271201800001IUSAspending$1,474,682Sep 8, 2023Sep 9, 2023 – Mar 8, 2025
Prime
Department of Health and Human Services
National Institutes of Health
NON-GMP SYNTHESIS OF COMPOUNDS. CURIA GLOBAL, INC. JULY 25, 2023 - JULY 24, 2024.—$288,375Jul 25, 2023Jul 25, 2023 – Jul 24, 2024
Prime
Department of Health and Human Services
National Institutes of Health
MCSP TORFP NO. NIH-NINDS-21-01: FLORIO (ANAGIN) - BASE EC (STROKE)HHSN271201800001IUSAspending$3,420,025Jun 30, 2023Jan 26, 2021 – Dec 1, 2024
Prime
Department of Health and Human Services
National Institutes of Health
GANESH (EMORY UNIVERSITY) - MCSP - HIT TO LEAD CHEMISTRYHHSN271201800001IUSAspending$2,873,043Jun 30, 2023May 9, 2022 – Dec 1, 2024
Prime
Department of Health and Human Services
National Institutes of Health
IGF::OT::IGF TASK ORDER NO. 3 MILLER LO - MEDICINAL CHEMISTRY SUPPORT PROGRAM FOR THERAPEUTIC DEVELOPMENTHHSN271201800001IUSAspending$1,297,588Jun 27, 2023Aug 1, 2018 – Nov 30, 2019
Prime
Department of Health and Human Services
National Institutes of Health
IGF::OT::IGF TASK ORDER NO. 4 - ROSENZWEIG-LIPSON - MSCP - LOHHSN271201800001IUSAspending$1,376,050Jun 27, 2023Aug 15, 2018 – Nov 30, 2019
Prime
Department of Health and Human Services
National Institutes of Health
MCSP TORFP NO. NIH-NINDS-20-02: MOURADIAN/DISNEY - BASE EC (PARKINSON'S)HHSN271201800001IUSAspending$1,392,674Jan 30, 2023Jun 1, 2020 – Aug 31, 2022
Prime
Department of Health and Human Services
National Institutes of Health
NON-CLINICAL SERVICES IDIQ75N93018D00008USAspending$443,000Sep 14, 2022Sep 14, 2022 – Dec 15, 2022
Prime
Department of Health and Human Services
National Institutes of Health
IGF::OT::IGF DMFP - TASK ORDER NO. 2 PETRUKHIN BPN-14967HHSN271201500005IUSAspending$1,325,649Jun 29, 2022Apr 1, 2015 – Jun 30, 2022

Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.

Subcontracting experience

11 records from government sources. Past participation is not evidence of current teaming interest.

RoleAgencyDescriptionVehicleObligatedAction datePeriod
Subcontractor
Department of Health and Human Services
"CURIA DESCRIPTION OF WORK NON-GMP MANUFACTURE OF APPROXIMATELY3 KILOGRAM OF STF-2586 AND REPROCESSING AND RETESTING OF STF- 2586 TASK 19: NON-GMP BATCH SUBTASK 19A: BATCH PROCEDURE/RECORD REVIEW AND APPROVAL SUBTASK 19B: MANUFACTURE, RELEASE, STABILITY "
63458883-184638
Parent award context
Parent award agency: Department of Health and Human Services · National Institutes of Health
Parent award NAICS: 541715
Parent award performance state: CA
Parent award description: COVID-19. TO DEVELOP SMALL SYNTHETIC CHEMICAL MOLECULES AS BROADLY ACTIVE ANTIVIRAL FOR THE TREATMENT OF VIRAL INFECTIONS.
View parent award on USAspending
—$207,900Jun 29, 2026— – —
Subcontractor
Department of Health and Human Services
"CURIA DESCRIPTION OF WORK NON-GMP MANUFACTURE OF APPROXIMATELY3 KILOGRAM OF STF-2586 AND REPROCESSING AND RETESTING OF STF- 2586 TASK 19: NON-GMP BATCH SUBTASK 19A: BATCH PROCEDURE/RECORD REVIEW AND APPROVAL SUBTASK 19B: MANUFACTURE, RELEASE, STABILITY "
63458883-184638
Parent award context
Parent award agency: Department of Health and Human Services · National Institutes of Health
Parent award NAICS: 541715
Parent award performance state: CA
Parent award description: COVID-19. TO DEVELOP SMALL SYNTHETIC CHEMICAL MOLECULES AS BROADLY ACTIVE ANTIVIRAL FOR THE TREATMENT OF VIRAL INFECTIONS.
View parent award on USAspending
—$13,300May 14, 2026— – —
Subcontractor
Department of Health and Human Services
"CURIA DESCRIPTION OF WORK NON-GMP MANUFACTURE OF APPROXIMATELY3 KILOGRAM OF STF-2586 AND REPROCESSING AND RETESTING OF STF- 2586 TASK 19: NON-GMP BATCH SUBTASK 19A: BATCH PROCEDURE/RECORD REVIEW AND APPROVAL SUBTASK 19B: MANUFACTURE, RELEASE, STABILITY "
63458883-184638
Parent award context
Parent award agency: Department of Health and Human Services · National Institutes of Health
Parent award NAICS: 541715
Parent award performance state: CA
Parent award description: COVID-19. TO DEVELOP SMALL SYNTHETIC CHEMICAL MOLECULES AS BROADLY ACTIVE ANTIVIRAL FOR THE TREATMENT OF VIRAL INFECTIONS.
View parent award on USAspending
—$844,600Jul 15, 2025— – —
Subcontractor
Department of Health and Human Services
"CURIA DESCRIPTION OF WORK NON-GMP MANUFACTURE OF APPROXIMATELY3 KILOGRAM OF STF-2586 AND REPROCESSING AND RETESTING OF STF- 2586 TASK 19: NON-GMP BATCH SUBTASK 19A: BATCH PROCEDURE/RECORD REVIEW AND APPROVAL SUBTASK 19B: MANUFACTURE, RELEASE, STABILITY "
63458883-184638
Parent award context
Parent award agency: Department of Health and Human Services · National Institutes of Health
Parent award NAICS: 541715
Parent award performance state: CA
Parent award description: COVID-19. TO DEVELOP SMALL SYNTHETIC CHEMICAL MOLECULES AS BROADLY ACTIVE ANTIVIRAL FOR THE TREATMENT OF VIRAL INFECTIONS.
View parent award on USAspending
—$56,600Jun 24, 2025— – —
Subcontractor
Department of Health and Human Services
"CURIA DESCRIPTION OF WORK NON-GMP MANUFACTURE OF APPROXIMATELY3 KILOGRAM OF STF-2586 AND REPROCESSING AND RETESTING OF STF- 2586 TASK 19: NON-GMP BATCH SUBTASK 19A: BATCH PROCEDURE/RECORD REVIEW AND APPROVAL SUBTASK 19B: MANUFACTURE, RELEASE, STABILITY "
63458883-184638
Parent award context
Parent award agency: Department of Health and Human Services · National Institutes of Health
Parent award NAICS: 541715
Parent award performance state: CA
Parent award description: COVID-19. TO DEVELOP SMALL SYNTHETIC CHEMICAL MOLECULES AS BROADLY ACTIVE ANTIVIRAL FOR THE TREATMENT OF VIRAL INFECTIONS.
View parent award on USAspending
—$337,600May 14, 2025— – —
Subcontractor
Department of Health and Human Services
"PERFORM ADDITIONAL PROCESS DEVELOPMENT ACTIVITIES TO ESTABLISH A SUITABLE PROCESS PRIOR TO THE 1 KG NON-GMP STF-4326 CAMPAIGN. THIS INCLUDES ONE-MONTH DEVELOPMENT WORK FOR THE SELECTED SALT FORM TO GET THE PROCESS READY FOR THE 1 KG SCALE; O PREPARE THE REQUESTED ~15 G OF THE SELECTED SALT FOR IN VIVO EVALUATION; AND O GENERATE A FINAL DEVELOPMENT REPORT."
63459539-184638
Parent award context
Parent award agency: Department of Health and Human Services · National Institutes of Health
Parent award NAICS: 541715
Parent award performance state: CA
Parent award description: COVID-19. TO DEVELOP SMALL SYNTHETIC CHEMICAL MOLECULES AS BROADLY ACTIVE ANTIVIRAL FOR THE TREATMENT OF VIRAL INFECTIONS.
View parent award on USAspending
—$34,500Dec 19, 2024— – —
Subcontractor
Department of Health and Human Services
"PERFORM ADDITIONAL PROCESS DEVELOPMENT ACTIVITIES TO ESTABLISH A SUITABLE PROCESS PRIOR TO THE 1 KG NON-GMP STF-4326 CAMPAIGN. THIS INCLUDES ONE-MONTH DEVELOPMENT WORK FOR THE SELECTED SALT FORM TO GET THE PROCESS READY FOR THE 1 KG SCALE; O PREPARE THE REQUESTED ~15 G OF THE SELECTED SALT FOR IN VIVO EVALUATION; AND O GENERATE A FINAL DEVELOPMENT REPORT."
63459539-184638
Parent award context
Parent award agency: Department of Health and Human Services · National Institutes of Health
Parent award NAICS: 541715
Parent award performance state: CA
Parent award description: COVID-19. TO DEVELOP SMALL SYNTHETIC CHEMICAL MOLECULES AS BROADLY ACTIVE ANTIVIRAL FOR THE TREATMENT OF VIRAL INFECTIONS.
View parent award on USAspending
—$116,000May 31, 2024— – —
Subcontractor
Department of Health and Human Services
"CURIA DESCRIPTION OF WORK NON-GMP MANUFACTURE OF APPROXIMATELY3 KILOGRAM OF STF-2586 AND REPROCESSING AND RETESTING OF STF- 2586 TASK 19: NON-GMP BATCH SUBTASK 19A: BATCH PROCEDURE/RECORD REVIEW AND APPROVAL SUBTASK 19B: MANUFACTURE, RELEASE, STABILITY "
63458883-184638
Parent award context
Parent award agency: Department of Health and Human Services · National Institutes of Health
Parent award NAICS: 541715
Parent award performance state: CA
Parent award description: COVID-19. TO DEVELOP SMALL SYNTHETIC CHEMICAL MOLECULES AS BROADLY ACTIVE ANTIVIRAL FOR THE TREATMENT OF VIRAL INFECTIONS.
View parent award on USAspending
—$206,500May 31, 2024— – —
Subcontractor
Department of Health and Human Services
"CURIA DESCRIPTION OF WORK AND TECHNICAL JUSTIFICATION PREPARATION OF 5 GRAMS OF STF-4326 FREE ACID, 5 GRAMS OF STF-4326 PHOSPHORIC ACID SALT, AND 5 GRAMS OF STF-4326 SODIUM SALT TASK 2: CHEMISTRY PROCESS/PRE-FORMULATION SUBTASK 2A: CHEMISTRY PROCESS SCALE-UP AND PROCESS OPTIMIZATION"
63065154-184638
Parent award context
Parent award agency: Department of Health and Human Services · National Institutes of Health
Parent award NAICS: 541715
Parent award performance state: CA
Parent award description: COVID-19. TO DEVELOP SMALL SYNTHETIC CHEMICAL MOLECULES AS BROADLY ACTIVE ANTIVIRAL FOR THE TREATMENT OF VIRAL INFECTIONS.
View parent award on USAspending
—$32,500May 29, 2024— – —
Subcontractor
Department of Health and Human Services
"CURIA DESCRIPTION OF WORK CONDUCT OF A PRELIMINARY SALT SCREEN AND EVALUATION OF PHYSICAL PROPERTIES OF SELECTED CANDIDATE. DETAIL DESCRIPTION OF WORK INVOLVED IS FOUND IN THE CURIA PROPOSAL, SEE SECTIONS 1.1 AND 1.2. BASE PERIOD TASK 2: CHEMISTRY PROCESS/PRE-FORMULATION SUBTASK 2C: POLYMORPH, SALT SCREEN AND API CHARACTERIZATION DRUG SUBSTANCE PREFORMULATION ACTIVITIES: STABILITY, SOLUBILITY AND CRYSTALLIZATION STUDIES"
63414670-184638
Parent award context
Parent award agency: Department of Health and Human Services · National Institutes of Health
Parent award NAICS: 541715
Parent award performance state: CA
Parent award description: COVID-19. TO DEVELOP SMALL SYNTHETIC CHEMICAL MOLECULES AS BROADLY ACTIVE ANTIVIRAL FOR THE TREATMENT OF VIRAL INFECTIONS.
View parent award on USAspending
—$182,583May 15, 2024— – —
Subcontractor
Department of Health and Human Services
CURIA RECENTLY MANUFACTURED NON-GMP STF-2586 AND IS FAMILIAR WITH THE SYNTHESIS PROCESS AND ANALYTICAL METHODS FOR STF-2586. CURIA€„¢S QUOTE IS THE BEST COMBINATION OF EXISTING KNOWLEDGE OF THE STF-2586 PROGRAM (AND HENCE THE STF-4326 PROGRAM AS STF-2586 IS A STARTING MATERIAL OF STF-4326), PRICE, FLEXIBILITY AND APPARENT TECHNICAL COMPETENCY AND QUALITY AND COVERED ALL OUR REQUIREMENTS. OTHER VENDORS WHO WERE VETTED FOR STF-2586 PRODRUG ARE LOCATED IN UK OR IN CHINA. CURIA IS LOCATED IN NY, USA, AND HENCE MAKING THE COMMUNICATIONS EASIER WITH THE STANFORD TEAM WHO IS LOCATED IN CA, USA. THEREFORE, WE CHOSE CURIA FOR PROCESS DEVELOPMENT OF STF-4326. CURIA PROVIDES EXTENSIVE KNOWLEDGE IN THE FIELD OF PROCESS CHEMISTRY AND MANUFACTURING. STANFORD LAB LACKS EXPERTISE IN TECHNICAL PROCESS CHEMISTRY WORK AND LARGER SCALE MANUFACTURING. FOR THESE ESSENTIAL ACTIVITIES WE REQUIRE A VENDOR THAT CAN PROVIDE US THIS EXPERTISE AND ENABLE US TO PROCEED WITH DRUG FORMULATIONS SUITABLE FOR NONCLINICAL STUDIES. CURIA IS A LEADING COMPANY WITH OVER 20+ YEARS OF EXPERIENCE WORKING WITH TOP PHARMACEUTICAL COMPANIES TO PROVIDE THE SERVICES WE REQUIRE IN ORDER TO SUCCESSFULLY ACHIEVE OUR PROGRAM GOALS. THEY ARE ABLE TO START THE WORK IMMEDIATELY, WHEREAS OTHER COMPANIES ARE NOT ABLE TO DO INITIATE THE WORK FOR SOMETIMES.
63065154-184638
Parent award context
Parent award agency: Department of Health and Human Services · National Institutes of Health
Parent award NAICS: 541715
Parent award performance state: CA
Parent award description: COVID-19. TO DEVELOP SMALL SYNTHETIC CHEMICAL MOLECULES AS BROADLY ACTIVE ANTIVIRAL FOR THE TREATMENT OF VIRAL INFECTIONS.
View parent award on USAspending
—$131,100Mar 10, 2023— – —

Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.

Agencies supported

  • Department of Health and Human ServicesGov-sourced

Government-sourced data comes from SAM.gov, SBA and USAspending.gov and is attributed to its source. Items marked company-reported were provided by the company and are verified by FedSub only where labeled. FedSub is a private company and is not affiliated with SBA, GSA/SAM.gov, or any government agency.

CURIA GLOBAL INC – Albany, NY | UEI ELCNZCS8GEA3 | FedSub